Bård Helge Smedsrød
Oprichter bij D'Liver AS
Profiel
Bård Helge Smedsrød is the founder and the Chief Scientific Officer of D'Liver AS, a company founded in 2011.
He held the position since 2011.
Mr. Smedsrød previously worked as an Associate Professor at the University of Uppsala from 1985 to 1988.
He then worked as a Professor at the University of Tromso.
Mr. Smedsrød obtained his undergraduate degree from the University of Oslo in 1975.
Actieve functies van Bård Helge Smedsrød
| Bedrijven | Functie | Begin |
|---|---|---|
D'Liver AS
 D'Liver AS BiotechnologyHealth Technology D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway. | Oprichter | 07-01-2011 |
Eerdere bekende functies van Bård Helge Smedsrød
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Uppsala | Corporate Officer/Principal | 01-01-1988 |
| University of Tromso | Corporate Officer/Principal | - |
Opleiding van Bård Helge Smedsrød
| University of Oslo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
D'Liver AS
D'Liver AS BiotechnologyHealth Technology D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway. | Health Technology |